Amanote Research
Register
Sign In
The uPA/uPAR System and suPAR in HIV Infection
doi 10.2174/978160805006211001010081
Full Text
Open PDF
Abstract
Available in
full text
Date
March 29, 2012
Authors
Unknown
Publisher
BENTHAM SCIENCE PUBLISHERS
Related search
uPA/uPAR System Activation Drives a Glycolytic Phenotype in Melanoma Cells
International Journal of Cancer
Cancer Research
Oncology
Plasminogen Activator Urokinase Receptor (PLAUR; uPAR; suPAR)
Science-Business eXchange
The Feasibility of uPA/uPAR-targeting Strategies in Cancer Treatment
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
A Cross-Talk Between Neuronal Urokinase-Type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain
Journal of Neuroscience
Neuroscience
The Role of uPA and uPA Inhibitors in Breast Cancer
Breast Care
Surgery
Oncology
uPA and uPAR shRNA Inhibit Angiogenesis via Enhanced Secretion of SVEGFR1 Independent of GM-CSF but Dependent on TIMP-1 in Endothelial and Glioblastoma Cells
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Down-Regulation of uPA and uPAR by 3,3′-Diindolylmethane Contributes to the Inhibition of Cell Growth and Migration of Breast Cancer Cells
Journal of Cellular Biochemistry
Biochemistry
Cell Biology
Molecular Biology
Targeting Chronic Central Nervous System HIV Infection
Antiviral Therapy
Infectious Diseases
Pharmacology
Microglia and the Urokinase Plasminogen Activator Receptor/uPA System in Innate Brain Inflammation
GLIA
Molecular Neuroscience
Neurology
Cellular
